IDM Pharma, Inc. (Nasdaq: IDMI) obtained definitive agreements from investors to purchase approximately 7.1 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE